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Abstract 
Background: Early detection of infection is critical to rapidly starting effective treatment. Diagnosis can be difficult, 
particularly in the intensive care unit (ICU) population. Because the presence of polymorphonuclear neutrophils in tis‑
sues is the hallmark of inflammatory processes, the objective of this proof of concept study was to determine whether 
the measurement of reactive oxygen species (ROS) could be an efficient diagnostic tool to rapidly diagnose infections 
in peritoneal, pleural and bronchoalveolar lavage (BAL) fluids in ICU patients.
Methods: We prospectively included all patients hospitalized in the 21‑bed surgical ICU of a teaching hospital from 
June 2010 to February 2014 who presented with systemic inflammatory response syndrome with suspicion of a 
peritoneal or pleural fluid or pulmonary infection needing a BAL. Instantaneous basal ROS production was measured 
in fluids and after phorbol 12‑myristate 13‑acetate (PMA) stimulation. We compared patients with infected fluids to 
those with non‑infected fluids.
Results: The overall ICU mortality rate was 34 %. A majority of patients were sampled following a delay of 5 days (2–12) 
after ICU admission, with most receiving antibiotics at the time of fluid sampling (71 %). Fluids were infected in 21/65 
samples: 6/17 peritoneal fluids, 8/28 pleural fluids and 7/20 BALs. ROS production was significantly higher in the infected 
than in the non‑infected group at baseline and after PMA stimulation in the peritoneal and pleural fluids but not in BAL.
Conclusion: Assessing instantaneous ROS production appears as a fast and reliable diagnostic method for detecting 
peritoneal and pleural fluid infection.
Keywords: Polymorphonuclear neutrophils, Inflammation, Infection, Critical care, Diagnosis, Bronchoalveolar lavage, 
Ascites, Pleural effusion, Reactive oxygen species
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Background
Patients with an infection while in the intensive care unit 
(ICU) have a higher mortality rate than non-infected 
ICU patients [1]. Unfortunately, delayed treatment of 
infections in the ICU has been shown to worsen prog-
nosis [2]. Because of this, analyses of blood samples and 
human fluids must be performed rapidly prior to the 
administration of broad-spectrum antibiotics, which are 
eventually adapted to the microbiological test results 
within the subsequent 48–72  h. The development of 
multidrug-resistant bacteria, first as part of the ecology 
of the patient population and then of the ICUs, highlights 
strongly the need to give antibiotics to infected patients 
only. Infection is difficult to diagnose when systemic 
inflammation is present for multiple potential reasons. 
In addition, the compartmentalization of infection may 
complicate the diagnostic strategy, necessitating a delay 
in the fluid sampling required to diagnose an infection. 
The availability of a more rapid test when infection is sus-
pected might be useful to eliminate sterile inflammation, 
confirm an infection in the tested compartment, or con-
sider the presence of infection even if direct examination 
was negative while awaiting culture results.
Polymorphonuclear neutrophils (PMNs) are the first 
line of defense against bacterial infection. In actual-
ity, the presence of PMNs in tissues is the hallmark of 
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inflammatory processes related to different triggers [3]. 
Among their activated functions, the production of reac-
tive oxygen species (ROS), mainly from NADPH oxidase 
activation, is an essential step in the killing of bacteria 
[4]. This property can be deleterious for tissue cells, espe-
cially when inflammation is sterile. We hypothesized that 
PMNs’ ROS production, as we previously published [5], 
could be higher during infection-induced inflammation 
than in sterile inflammation. This could help diagnose 




This study was approved by the Ethical Committee of 
the “Société de Réanimation de Langue Française” (CE 
SRLF 14-07), which waived the requirement of written 
informed consent. Information about this research pro-
tocol, however, had to be given to the patient if possible 
or to his/her relatives. Data were collected in the 21-bed 
surgical ICU of a teaching hospital from June 2010 to 
February 2014. Patients were screened when they had a 
systemic inflammatory response syndrome (SIRS) and 
when a peritoneal, pleural or pulmonary infection was 
suspected. Fluids from the peritoneum, pleural space or 
bronchoalveolar lavage were sampled for the diagnosis 
of infection according to the decision of the independent 
intensivist in charge.
Definitions of infection
Peritoneal fluid infection was diagnosed in accordance 
with recommendations from the 2007 French Con-
sensus Conference [6] and international guidelines [7]. 
These included the presence of bacteria after culture or 
PMN count ≥250/mm3 associated with local or general 
symptoms of inflammation. A determination of infected 
pleural fluid was made when the quantitative culture was 
positive for bacteria as defined by Light et al. [8]. Histo-
logic findings describing the purulent sample were also 
used to identify pleural infection [9, 10]. Lung infection 
detected by BAL was defined by a bacterial quantitative 
culture ≥104  CFU/ml [11–14], with a cell count ≥105/
mm3 containing more than 50 % PMNs [15].
Data collection
The collected data included demographic characteris-
tics (age, sex), reason for admission to the ICU, sever-
ity scores (Sequential Organ Failure Assessment Score: 
SOFA and Simplified Acute Physiology Score: SAPS II), 
duration of time from admission to fluid sample analysis 
and outcome.
Concomitant sites of infection and the antibiotic regi-
men, if any, were also recorded. The physician in charge 
decided all fluid samplings. BAL was performed using a 
classic protocol. Specifically, 100 ml of saline was gently 
injected during bronchoscopy and retrieved from the 
lung area of interest, before being aliquoted in three dif-
ferent tubes. Fluid samples were analyzed within 2 h after 
collection with a leukocyte and PMN count, protein level 
and ratio with plasma level, and the presence or not of 
bacteria before culture. In addition to the routine check-
ing, ROS measurement was performed immediately on 
fresh samples.
Measurements of ROS production by luminometry
ROS production was measured according to the method 
previously described [5, 16]. Briefly, a fluid sample 
(250  μl) was diluted in Hanks’ balanced salt solution 
(HBSS; Invitrogen, Cergy-Pontoise, France) to a final vol-
ume of 1  ml and then incubated with luminol (50  μM; 
Sigma) for 10 min at 37  °C in the dark. As a functional 
test, basal production of ROS (basal condition) was 
compared with a sample that had been stimulated with 
10−7 M of phorbol 12-myristate 13-acetate (PMA; Sigma) 
added in sample just before luminometry allowing a 
dynamic approach of PMN ROS production; each con-
dition was assayed in duplicate. Immediate analysis was 
conducted during a 20-min period using a luminometer 
(AutoLumat Plus LB 953; Berthold Technologies, Bad 
Wildbad, Germany). The signal was recorded as relative 
light units (RLUs) for a duration of 1 s every minute. The 
results were expressed as the area under the curve (AUC) 
of luminescence during the 20 min (Additional file 1: Fig-
ure S1). The time delay before having the quantitative 
level of ROS production averaged 35  min per patient. 
Considering the status of circulating cells as the refer-
ence, the ROS measurements in fluid were compared to 
those obtained from whole blood (40 μl) sampled at the 
same period of day in the same patient and to healthy 
volunteers’ blood. The potential variability in the reac-
tivity of luminol was avoided by regularly preparing new 
luminol solutions and repeating tests over several weeks 
with decreasing concentrations of stable H2O2 (Chimie 
Recherche Environnement Evolution, Taverny, France). 
We repeated tests in each of seven patients’ blood sam-
ples and showed a good reproducibility of AUC calcula-
tion: Correlation test showed R = 0.99 and 0.90 in control 
and PMA conditions, respectively (p < 0.0001).
Statistical analysis
Quantitative variables are expressed as the median 
and interquartile range, while qualitative variables are 
expressed as the percentage. Nonparametric Mann–
Whitney, Wilcoxon’s paired test and Chi-square tests 
were used when appropriate, with the alpha set to 0.05. 
The respective role of the individual cell activity versus 
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the number of cells on global ROS production was tested 
by comparing the AUC after normalization (or not) 
by the number of cells. We also used correlation tables 
using Statview® (Statview®, SAS Institute Inc. Copyright, 
North Carolina, USA).
Strategy for analysis
First, the ROS production per PMN in healthy volun-
teer blood was compared to the values obtained in our 
cohort. Within the cohort, the ROS production per PMN 
in blood was compared to ROS production in fluids. 
ROS production in fluids was then compared between 
infected and non-infected fluids.
Results
During the study period, 312 patients had peritoneal, 
pleural or BAL fluid sampling. Among them, we ana-
lyzed 67 patients with SIRS and suspected of having an 
infection requiring fluid sampling that was also analyzed 
for ROS analysis (flow chart, Fig. 1). Nine patients with 
a BAL containing <105  cell count/mm3 were excluded 
from the analysis. Finally, 58 patients were analyzed with 
17 peritoneal fluid samples, 28 pleural fluid samples and 
20 BALs. Some patients were explored at different sites. 
Sample characteristics are summarized in Table 1. In the 
group with peritoneal fluid analysis, the reason for ICU 
admission was mainly the presence of postoperative peri-
tonitis, gut hemorrhage and acute respiratory failure. The 
pleural fluid and BAL groups essentially had acute respir-
atory failure, major trauma or heavy surgical procedure.
The overall ICU mortality rate was 34 %, with 47 % of 
the infected group and 29  % of the non-infected group 
(p =  0.21). Fluids were infected in 21/65 fluid samples, 
including 6/17 peritoneal fluids (only one fluid was con-
sidered infected due to 730 PMNs/ml and no bacteria 
cultured), 8/28 pleural fluids and 7/20 BALs. The most 
frequently identified bacterium in the thoracic samples 
was Pseudomonas aeruginosa (2/8 in pleural fluid; 2/7 
in BAL). Enterobacteriaceae (2/6) and Candida sp. (3/6) 
were the most frequent microorganisms in peritoneal 
fluid. A majority of patients (71 %) were treated with anti-
biotics at the time of sampling. Blood samples isolated 
bacteremia in three patients. The proportion of patients 
receiving steroid treatment was the same in the infected 
and non-infected groups with 12 and 15 %, respectively 
(p = 0.77).
ROS production in blood in patients compared 
with healthy volunteers
Compared with healthy volunteers (HV), patients had 
a significantly higher leukocyte count [13,800/mm3 
(11,175–23,800) vs 5400/mm3 (4500–6400), p < 0.0001] 
and a higher PMN count [11,023/mm3 (8747–20,742) 
vs 3700/mm3 (2510–4295), p < 0.0001]. While the ROS 
production in blood (AUC/PMN) after PMA stimula-
tion was significantly higher in patients than in HVs, 
this was not observed in the basal condition (Fig. 2). As 
expected, such a difference was largely significant in the 
absence of cell normalization in the basal condition and 
after stimulation, potentially reflecting the “global oxi-
dative stress” in patients’ blood, mainly due to PMNs 
(data not shown).
Comparison of ROS production between blood and fluids 
in patients
The ROS production per PMN in peritoneal fluid was sig-
nificantly higher than that in blood, in both the basal and 
PMA conditions (Fig. 3a). Similar results were observed 
for pleural fluid in the basal condition and after PMA 
stimulation (Fig. 3b).
For BAL, no difference was observed in the basal con-
dition. After PMA stimulation, the AUC/PMN in the 
BAL was lower than the AUC/PMN in blood (Fig. 3c).
Nine fluids did not have a corresponding blood sample 
analyzed.
Fig. 1 Study flow chart. 58 patients analyzed, corresponding to 17 
peritoneal liquids, 28 pleural liquids and 20 bronchoalveolar lavages
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ROS production in fluids
Peritoneal fluid
Among the 17 peritoneal fluid samples, six (35  %) were 
diagnosed as infected with a median PMN count of 
400/mm3 (361–400) versus 22/mm3 (4–32) in the non-
infected group (p  =  0.002). Twelve were primary peri-
tonitis and five were secondary peritonitis. Basal ROS 
production was significantly higher in the infected group 
versus the non-infected group (Fig.  4) and after PMA 
stimulation (Additional file  2: Figure S2). Such a differ-
ence was not observed after normalization per PMN 
(data not shown). Correlation between PMN count and 
ROS production was 0.82 in basal condition and 0.13 
with PMA (Additional file 3: Figure S3A).
Pleural fluid
Among the 28 pleural fluid samples, eight (29  %) were 
diagnosed as infected but with no difference in the 
PMN count from that of the non-infected group [693/
mm3 (337–21,953) and 478/mm3 (121–2237), respec-
tively (p  =  0.4)]. The ROS production was significantly 
higher in the infected fluid under both the basal (Fig. 4) 
and stimulated conditions (Additional file  1: Figure S1). 
No difference was observed after normalization per 
PMN (data not shown). No correlation was established 
between PMN count and ROS production in basal condi-
tion and PMA (Additional file 3: Figure S3B).
Bronchoalveolar lavage
Seven (35 %) BALs among the 20 samples were diagnosed 
as infected. The PMN count did not differ significantly 
Table 1 Characteristics of patients according to the presence of infection in the biological sample
Quantitative variables are expressed as medians (25th–75th percentiles) and qualitative variables as frequencies (%)
ICU intensive care unit, SOFA Sequential Organ Failure Assessment Score, SIRS systemic inflammation response syndrome, SAPS II Simplified Acute Physiology Score, 
PMN polymorphonuclear neutrophils
Infected (n = 17) Non-infected (n = 41) All patients
Age (years) 58 (53–66) 59 (49–73) 59 (51–72)
Male sex 9 (53 %) 2 (59 %) 33 (57 %)
SIRS 17 (100 %) 41 (100 %) 58 (100 %)
Temperature (°C) 37.5 (37–38) 37.4 (36.6–38) 37.5 (36.6–38)
SOFA 8 (5–10) 7 (4–11) 7 (4–10)
SAPS II 51 (41–57) 41 (32–46) 43 (34–51)
ICU mortality n (%) 8 (47 %) 12 (29 %) 20 (34 %)
Time between ICU admission and sample analysis (days) 10 (1–20) 4 (2–9) 5 (2–12)
Blood PMN (/mm3) 14,904 (10,647–22,400) 10,530 (8550–17,860) 11,023 (8747–20,742)
Antibiotics at the time of sampling 14 (82 %) 27 (66 %) 41 (71 %)
Steroid treatment at the time of sampling 2 (12 %) 6 (15 %) 8 (14 %)
Fig. 2 Healthy volunteers and patients’ ROS production per PMN in 
the blood. a Basal ROS production [area under the curve (AUC), loga‑
rithmic scale] per PMN in blood. Healthy volunteers: n = 21; patients: 
n = 49. b ROS production after PMA stimulation per PMN in blood. 
Healthy volunteers: n = 21; patients: n = 49. Box plot represents 
median and 25–75 % interquartile
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[59,250/mm3 (27,000–264,300) vs 118,900/mm3 (98,895–
398,400) between the groups with or without infec-
tion (p = 0.43)]. ROS production in the basal condition 
or after PMA stimulation was not significantly different 
between the infected and non-infected groups (Fig.  4). 
No difference was observed after normalization per 
PMN (data not shown). No correlation was established 
between PMN count and ROS production in basal condi-
tion and PMA (Additional file 3: Figure S3C).
Discussion
The results of this preliminary study observed that ROS 
production was higher in the infected peritoneal and 
pleural fluids, an effect that was not observed in BAL. 
Measurement of ROS production could be a potential 
early screening method for detecting the presence of bac-
teria in patients’ biological fluids.
The ICU context is challenging for infection diagnosis 
because a high proportion of patients receive antibiotics 
and exhibit systemic inflammation symptoms that can 
relate to many different etiologies. The studied cohort 
was severe, with a high median SAPS II (43) and an 
overall ICU mortality rate of 34 %. Fluids were sampled 
after a median delay of 5 days post-admission, and 71 % 
of these patients received antibiotics at the time of sam-
pling; furthermore, the infected and non-infected groups 
did not differ in body temperature or blood PMN count; 
therefore, the blood leukocyte count in the present study 
did not help differentiate between sterile and infection-
induced inflammation.
We hypothesized that the functional capability of PMNs 
close to the infected organ, especially the release of ROS, 
might help to separate these mechanisms of inflamma-
tion. If this hypothesis is valid, it may speed the diagno-
sis of infection because the ROS test requires only a few 
minutes versus hours to days for microbiological exams. 
The clinical decision to administer, change, or stop anti-
biotics could then be made more rapidly. If prescribed 
after screening for a positive ROS test, antibiotics could 
be adapted later based on the findings from microbiology 
scans for the type and sensitivity of the bacteria. Alterna-
tive diagnostic methods for detecting infected peritoneal 
and pleural liquids and BAL have been studied [17–22]. 
However, most of them excluded critically ill and post-
operative patients and those receiving antibiotics. The 
present results on ROS correspond to an instantaneous 
production [5, 16], which differs from other techniques 
based on an accumulation of altered fluid components by 
ROS (nitrosylated and oxidated proteins) [23].
The hypothesis that the production of ROS by PMNs 
would be higher from fluid samples closer to the infected 
organ than in sterile inflammation is reasonable. PMNs 
are the first-line cell type in innate immunity and are 
activated by the presence of bacteria, with the stimula-
tion of NADPH oxidase [4, 24–26]. NADPH oxidase is 
assembled at the surface of the phagosome and at the cell 
surface. Its activation allows the production of superox-
ide anion and hydrogen peroxide. This ROS production 
Fig. 3 Comparison of ROS production between blood and fluids 
from patients. ROS production [area under the curve (AUC), loga‑
rithmic scale] per PMN in peritoneal liquid and blood (a, n = 12), 
pleural liquid and blood (b, n = 23) and BAL and blood (c, n = 19), 
under basal conditions and after PMA stimulation. Box plot represents 
median and 25–75 % interquartile
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damages proteins, DNA and membranes, activates den-
dritic cells [27], participates in the activation of lym-
phocytes [28] and the production of pro-inflammatory 
cytokines [29] and activates the inflammasome [30].
In the present study, the ROS production per PMN in 
biological fluids was higher than the ROS production per 
PMN in the blood, except for BAL fluid. Indeed, leuko-
cytes that infiltrate tissues are activated as they roll on 
the endothelial surface due to chemoattractant agents 
related to pathogens or damage-associated molecu-
lar patterns (DAMPs) [31]. Therefore, the difference 
observed in peritoneal and pleural fluid was not related 
to that status of PMNs in the blood circulation before 
infiltration.
The main result of this study is the major increase in 
ROS production at baseline and after PMA stimulation 
in peritoneal and pleural infected fluids compared with 
non-infected fluids in inflammatory patients. ROS were 
always measurable even in complex inflammatory fluids 
with PMN impossible to count. The difference between 
infected and non-infected groups was not solely due to a 
higher PMN count since correlations between PMN count 
and ROS production were low, except for peritoneal liquid 
tested in basal condition (Additional file 3: Figure S3A, B, 
C). Exposition to DAMPs, ischemia and aging are some 
non-infectious stimuli inducing PMN recruitment to tis-
sues and ROS production [32–35]. Therefore, the obser-
vation of a higher amount of ROS during infection in this 
very specific inflammatory ICU population strengthens 
the observed results. Additionally, it appeared that there 
are distinct pathways for neutrophil attraction toward ster-
ile or non-sterile foci. It was demonstrated that hydrogen 
peroxide (H2O2) and ROS formation was dispensable for 
leukocyte recruitment during bacterial infection and not 
for sterile inflammation. This may fit well with the find-
ings of higher ROS production in infected versus non-
infected tissue [3, 36]. For these reasons, we considered 
that ROS test would be adapted to different complex situ-
ations of ICU practice for early triage of infection source, 
before results of PMN count or microbiology in suspected 
infected fluid.
We did not observe any association regarding BAL 
between ROS production and the infection status. One 
explanation could pertain to the fact that BAL was con-
sidered infected if a culture was found to be ≥104 CFU/
ml [11], and then 20 % of samples had an infra-threshold 
bacteria culture that led to the elimination of infection 
rather than colonization, which might have increased 
ROS production. Furthermore, if macrophages predomi-
nated in non-infected BAL, they could produce ROS 
such as PMN and increase ROS levels in the non-infected 
group. Nevertheless, ROS measure does not seem suit-
able as a preliminary infection diagnostic tool for BAL 
due to the heterogeneity of its realization; it should be 
assessed in a specific study.
The first limit of our study was the small effective; 
herein we present preliminary results supporting the 
potential interest for early screening of different types of 
fluids in addition to CSF [16]. This approach would be of 
particular interest for the early screening of infection at 
patient’s admission as a complement to bacteria identi-
fication technics among which PCR and mass spectros-
copy will considerably speed up infection diagnosis. Even 
if we were cautious for reagent quality and experiment 
Fig. 4 ROS production in fluids from patients according to infection. ROS production under basal conditions according to infection [area under 
the curve (AUC), logarithmic scale]. Number of patients with peritoneal fluid (infected/non‑infected) n = 17 (6/11), pleural fluid n = 28 (8/20) and 
bronchoalveolar lavage (BAL) n = 20 (7/13). Box plot represents median and 25–75 % interquartile
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conditions, we have to develop a standardized test before 
transposition to clinical practice.
Our study was limited by the small effectives with high 
variability of cell count in fluids for clarifying the impact 
of PMN count on test results. High ROS production in 
infected fluid might not only result from PMN number 
but also from ROS activity per PMN. The only correla-
tion, between cell number and ROS production, was in 
peritoneal samples. This could result from the definition 
of infection only, because this definition was based on 
cell number in samples, when it was not the case for the 
other fluids.
Conclusion
The measurement of instantaneous ROS production in 
peritoneal and pleural fluids appears to be an efficient 
and rapid method for diagnosing infection, and it was 
not suitable for BAL. This method may help speed the 
diagnosis of peritoneal and pleural infection, as well as 
decrease the cost and delay in the administration of anti-
biotics. These preliminary results should be confirmed 
in a prospective multicenter study in order to define an 
adequate threshold, using a standardized test.
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